Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 10, 2008

Business Wire,  Feb 28, 2008  

• E-mail
• Print
• Link

AMITYVILLE, N.Y. -- Second graph, first sentence should read: To access the conference call, dial toll free 888-713-4214, or 617-213-4866 for international callers, five minutes before the conference (sted To access the conference call, dial toll free 866-713-4214, or 617-213-4866 for international callers, five minutes before the conference).

The corrected release reads:

HI-TECH PHARMACAL TO RELEASE THIRD QUARTER EARNINGS AND HOLD CONFERENCE CALL ON MARCH 10, 2008

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal Year 2008 ended January 31, 2008, prior to the market opening on Monday March 10, 2008 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.

To access the conference call, dial toll free 888-713-4214, or 617-213-4866 for international callers, five minutes before the conference. The passcode of the conference call is 69126880.

Callers can pre-register for the call at the following web site to expedite joining the call that morning: https://www.theconferencingservice.com/prereg/key.process?key= PECDBFVE4. (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

A replay of the conference call will be available after 12 p.m. on March 10, 2008, for one week by calling toll free 888-286-8010, or 617-801-6888 for international callers. The passcode for the replay is 90587478.

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace.

Forward-looking statements (statements which are not historical facts) in this Press Release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not promises or guarantees and investors are cautioned that all forward-looking statements involve risks and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, the regulatory environment, including without limitation, reliance on key strategic alliances, availability of raw materials, fluctuations in operating results and other results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. These statements are based on management's current expectations and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward looking statements which speak only as of the date made. Hi-Tech is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning